HONA

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

✗

Return

+2.55%

Status

scored

Reduce HONA to 50-60% of benchmark Industrials/A&D weight using a three-tranche scaled execution: first tranche (40% of trim) via limit orders at the $155.86/$158.51/$165.11 resistance convergence, second tranche (40%) only on confirmed break below $146.30 with volume exceeding 5M shares for 2 consecutive sessions, and residual 20% core position (1-2% portfolio risk) maintained for franchise-quality optionality. Hard $146.30 stop with volume gating is required rather than single-clip execution, with re-evaluation hard-bound to Q3 2026 earnings (late October/early November).

Outcome

–

Return

+0.61%

Status

scored

Reduce HONA to 50-60% of benchmark weight via scaled three-tranche execution, as Q3 earnings resolved without the expected recovery re-rating, confirming the structural-damage framework and breaking the prior Hold-with-catalyst thesis. Sell Tranche 1 (40% of trim) into the $166-170 resistance zone where 10 EMA, Bollinger mid, 50 SMA, and upper band converge—not at $156.27 with a tight stop that will get whipsawed by normal ATR in a compressed-volatility basing pattern. Deploy Tranche 2 (40% of trim) only on confirmed capitulation below $148.72 on volume >5M shares for 2 consecutive sessions. Maintain Tranche 3 (20% of trim) as a 1-2% portfolio-risk core to capture defense tailwind and franchise quality, with no redeployment into peers or leverage/options in the hostile macro environment.

Outcome

✗

Return

-2.74%

Status

scored

Maintain HONA at current sizing with a hard $148.45 stop-loss; do not add below $150 until Q3 earnings confirm recovery, and do not trim into strength below $167. The HOLD rating is the only defensible position given the structural bull case remains unconfirmed while the bear case has been repeatedly absorbed by the $148.45 defended floor and sector tailwinds.

Outcome

✓

Return

+1.06%

Status

scored

Maintain HONA at current $155.74 exposure with a hard $148 stop (volume-confirmed close below on >5M shares for 2 consecutive sessions) and a $168 upgrade trigger (close above $168 with volume AND MACD histogram expansion above +0.50). Do not add on weakness or trim into rallies—do not tighten stop from $148 to $151 as this would be emotional risk management. Q3 2026 earnings (late October/early November) is the binding re-evaluation catalyst, with downgrade conditions including close below $148 on volume OR earnings showing SG&A stickiness with no margin recovery above 16%.

Outcome

–

Return

+0.72%

Status

scored

Trim HONA exposure by 10-15% via single-clip execution at next session open, with a hard $148.50 stop and volume confirmation (>5M shares for 2 consecutive sessions). Q3 2026 earnings (late Oct/early Nov) is the binding binary re-evaluation catalyst — pre-committing further directional exposure ahead of that print is the documented alpha-leakage path per multiple prior reflections. No redeployment into defense or industrial peers; cash earns the risk-free rate and preserves optionality.

Outcome

–

Return

+0.36%

Status

scored

Analysts recommend trimming HONA by 15-20% via single-clip execution at next session open, with a hard $148 stop-loss requiring volume confirmation (>5M shares for 2 consecutive sessions). The Underweight rating reflects intact deterioration data (SG&A +88.5% YoY, FCF/interest coverage of 0.21x, tax rate spike to 32.3%) but acknowledges a defended $148.50 structural floor and prior alpha burn from over-aggressive trims, warranting a smaller position reduction than the trader's 30-50% proposal. A binding time-stop is set for Q3 2026 earnings (late October/early November) to force reassessment and prevent silent alpha bleed, with no redeployment into defense, cyclical names, or leveraged instruments.

Outcome

–

Return

-0.58%

Status

scored

Trim HONA to 50-60% of benchmark Industrials/Aerospace & Defense weight via single-clip execution at next session open, avoiding staged architecture. Hard residual stop set at $148.50 with volume confirmation (>5M shares for 2 sessions) below the lower Bollinger band and structural floor. Q3 2026 earnings (late October/early November) is the binary re-evaluation catalyst; pressing into a full Sell before that print is explicitly contraindicated given the documented pattern where defense tailwinds absorbed leverage/FCF stress across multiple quarters and produced +2.2% alpha against the prior Sell call.

Outcome

✗

Return

-0.30%

Status

scored

Underweight HONA with a staged trim of ~60% of current weight, executing 40% now at $157.50 and reserving 20% for a tactical squeeze toward $160-165, with residual capped at 1.0% NAV. Stop loss placed at $148.50 (Bollinger lower band). No redeployment into cyclicals recommended; cash preserves optionality given higher-for-longer rates. Q3 2026 earnings (late October/early November) is the explicit re-evaluation catalyst, with upgrade thresholds requiring margin stabilization above 16-17%, FCF above $1.6B annualized, and EPS above $8.00.

Outcome

✗

Return

+2.05%

Status

scored

HONA receives a Sell rating across all three risk analysts due to converging bearish signals including a mathematically heroic $9 EPS estimate vs. realistic normalized EPS of $6.50-7.00 (implying 22-23x PE), failed index inclusion (-2.11% move), five failed rallies at $167-170 signaling distribution, unsustainable FCF of ~$172M vs. $800M interest expense, and zero technical reversal triggers firing. Position sizing recommends trimming to half typical industrial allocation and using $160 (10 EMA) as a tactical exit zone for relief bounces, with hard stop at $174 and price target at $148.50; new shorts should await confirmed breakdown below $148.50 or failed rally setup, and fresh longs should wait for at least two technical reversal triggers to fire.

Outcome

✗

Return

-4.07%

Status

scored

Maintain HONA at current weight without new capital deployment or trimming; hard stop exits at $145 on volume-confirmed close. New entries require 3-of-5 confirmation triggers including 50 SMA reclaim at $174.35 on volume ≥15M, Q3 operating margin >16%, Q3 SG&A decline from $722M, forward EPS holding at $9+ for two months, and Net Debt/EBITDA <4.0x. If triggers confirm, size at 50-60% of normal allocation using 2.5x ATR stops (~$17). Hold reflects that operational quality (Q2 revenue +5.4% YoY, deferred revenue visibility, defense tailwinds) does not justify full exposure to unresolved structural risks (unaccounted debt proceeds, accelerating SG&A, CEO credibility overhang, hostile macro) until Q3 earnings print validates the bull case. Failure on any single trigger or 2-session close below $149.80 floor warrants downgrade to Underweight or full Sell exit respectively.

Outcome

✓

Return

-2.98%

Status

scored

HONA rated Underweight with a $150 price target and 4-6 week horizon to Q3 2026 earnings (late October/early November). Analysts recommend trimming exposure to 50-60% of benchmark weight through phased execution: 30-40% trim at current ~$163 levels, then another 20-30% on any rally into the $167-$169 resistance zone, with a stop on close above $158. Downside targets are $140→$130 on confirmed daily close below $150 on ≥8M shares, and residual exposure should be hedged with a January 2027 $150/$130 put spread.

Outcome

✓

Return

-2.38%

Status

scored

The analysis resolves to Underweight with directional Sell execution, advocating aggressive trimming of HONA exposure to 50-60% of benchmark weight while avoiding new long entries at current $167-170 levels. The structural impairments—negative book equity of -$5.7B, 4.18x net leverage, $800M annualized interest expense, and forward EPS requiring near-tripling from a -71% YoY collapse—directly contradict the structural-floor defense doctrine that justified prior Hold calls. Re-engagement requires either a confirmed close above $177.31 (50 SMA) on >5M volume or a $149.70 retest for risk-defined entries, with the Q3 2026 earnings (mid-to-late October) serving as the binary resolution catalyst.

Outcome

✓

Return

-1.01%

Status

scored

Analysts recommend trimming HONA to neutral weight at $169, maintaining Underweight rating due to 4.18x net leverage (highest in aerospace peer set), H1 2026 FCF collapse to $86M (–89% YoY), negative book equity (-$5.7B) removing 30-40% of institutional buyer screens, and CEO credibility damage. The $150.42 structural floor remains defended with quantified absorption mechanics ($1.06B cash, $3.2B TTM FCF, $2.68B deferred revenue, 4x interest coverage, IndiGo 810-aircraft backlog), preventing a full Sell recommendation.

Outcome

✗

Return

+3.32%

Status

scored

Reduce HONA exposure by 30-35% on any test of the $165-$172 zone, with hard stop at $150. Re-evaluate at Q3 2026 earnings as the binary catalyst — upgrade to Hold only on confirmed margin recovery and deleveraging guidance; downgrade to Sell on close below $149.

Outcome

✓

Return

-2.11%

Status

scored

Maintain HONA at benchmark weight with active patience into Q3 2026 earnings (late October/early November). Execute trim-on-rallies discipline by reducing 25-30% of position on rallies into the $169-172 resistance zone, while maintaining hard stop at $149.80 on daily close with volume >5M shares for two consecutive sessions.

Outcome

✓

Return

+1.80%

Status

scored

Maintain HONA at benchmark weight with no additions or trims at current $164 levels; trim 25-30% of position on rallies into the $169-172 resistance zone to monetize consolidation. Hard stop at $149.80 lower Bollinger Band on daily close; Q3 2026 earnings (late October/early November) is the binary catalyst that will resolve directional ambiguity.

Outcome

✗

Return

+3.58%

Status

scored

The multi-agent consensus shifts to Underweight based on negative book equity (-$5.7B), 4.2x leverage, and structural gross margin compression (38.3% → 34.8%) contradicting prior Hold frameworks. Existing longs should be trimmed 30-50% on rallies into the $164-169 resistance zone via covered calls, while tactical shorts target $150 then $135 with stops above $172. Q3 2026 earnings (late Oct/early Nov) serves as the binary resolution catalyst, with new long exposure gated on either confirmed close above $183 on above-average volume or decisive failure of $150-152 support.

Outcome

✗

Return

-3.40%

Status

scored

Maintain HONA at current weight with no incremental capital deployment at $164; risk/reward is roughly 2-to-1 against a breakout at current levels (3.7% upside to $170 vs 7.9% downside to $151). Q3 2026 earnings in late Oct/early Nov is the binary resolution event for this 6-10 week tactical hold. The asymmetric entry the bull describes exists at $140-145, not at $164, and the binding constraint is the nine-consecutive prior decision architecture (five failed Underweights/Sells and four Holds) rather than fresh directional conviction.

Outcome

✗

Return

+3.68%

Status

scored

Maintain Hold on HONA as the three-analyst consensus correctly rejects both aggressive upside scaling and systematic bearish architectures in favor of calibrated refinement. The structural floor ($1.06B cash, $3.2B FCF, 4x interest coverage, IndiGo 810-aircraft backlog) has absorbed seven consecutive bearish catalysts, while the $158–170 stacked resistance zone warrants avoiding additions. Q3 2026 earnings (late October/early November) serves as the binary resolution event, with $175 price target and $144 hard stop on new tranches.

Outcome

✗

Return

+2.93%

Status

scored

Reduce an existing overweight position toward 50-75% of normal allocation (0.5-1.0% portfolio risk) via staged limit orders in the $154-160 zone, with the stop widened to $143. Add an acceleration exit trigger: a close below $149 on >3M volume triggers full exit of residual. Cap re-engagement at 1.5% of portfolio with primary re-entry at sustained close >$170 on volume with deleveraging evidence, or secondary re-entry at $162-165 on MACD positive crossover with confirmed higher low. No fresh long until Q3 2026 earnings resolves the $9.08 forward-EPS thesis.

Outcome

✗

Return

+1.43%

Status

scored

Sell HONA with a 60-70% trim via staged limit orders into the $155-161 zone while reserving 30-40% residual as a contingent hedge pending a basing-low reclaim above $156 on >3M volume within 5 sessions; position new shorts below $1% of book given the 7.92 ATR with a $165 stop. The price has broken below the $156 basing low after 35 consecutive sessions of lower highs and lower lows, with a death cross forming between the 50 SMA ($189) and 200 SMA, confirming the regime change. Q3 2026 earnings (late October/early November) serves as the binary catalyst requiring all four re-engagement triggers for the residual position.

Outcome

✓

Return

-2.47%

Status

scored

Reject the trader's SELL recommendation as it replicates the empirically-failed trim-and-residual architecture documented across five consecutive Underweight/Sell failures; also reject the Aggressive's BUY due to unconfirmed technical reversal and high dependency stack. Maintain the Neutral's HOLD with 1-2% benchmark weight, integrate the SPY-relative gate (auto-trim to 0.5% if XLI underperforms >3% over 20 sessions), and hold $145 put hedges as tail insurance while awaiting the Q3 binary catalyst.

Outcome

✗

Return

-3.47%

Status

scored

Maintain HONA at 1-2% benchmark weight with no incremental capital deployment at $161, as the structural floor at $156-164 has absorbed every bear catalyst across six prior decisions. Execute Q4-expiry $145 protective puts as 10-15bps portfolio-level tail insurance; Q3'26 earnings (late October) is the binary catalyst that resolves margin trajectory and FCF coverage.

Outcome

✗

Return

+3.90%

Status

scored

Maintain HONA at 50% allocation with $148 hard stop pending Q3 2026 earnings as the validating binary event for the $9.08 forward EPS thesis; the HOLD decision is anchored in three independent failures (Underweight destroyed alpha three consecutive times in three weeks, Full Sell produced negative alpha due to structural floor support from $1.06B cash and $3.2B TTM FCF), with four-variable alignment required to confirm the bull case and ambiguous institutional options activity warranting patience over aggressive re-engagement.

Outcome

✗

Return

+1.58%

Status

scored

Trim 75-85% of HONA exposure in tranches at $158-165 using limit orders, executing 40-50% on first relief-bounce and balance on VWMA test at $163.62; keep residual below 25bps of book with $148 hard stop. Avoid selling into the $150-152 capitulation zone and defer peer redeployment into RTX/LHX/GD until Q3 2026 earnings print.

Outcome

✓

Return

-1.10%

Status

scored

The analysts recommend trimming 65-75% of HONA exposure in staged tranches at $162-165 and $168-170, maintaining a residual 25-30% (~50-75bps of book) sized to survive a 12% adverse move with a hard stop at $148 closing basis. The bearish thesis rests on collapsed TTM EPS of $3.27 (down 64% from $9.11), negative book equity of -$5.7B, 4.2x net leverage, and a forward EPS consensus requiring a 178% rebound the team views as unlikely, with Q3 2026 earnings in late October/early November serving as the binary checkpoint for the trade.

Outcome

✓

Return

-2.45%

Status

scored

Escalating to Sell given structural floor concession is itself a forecast that floor will hold—trim 75-100% of HONA exposure scaled into the $161-165 zone. If keeping a stub, cap at <25bps with $150-152 closing stop; reject trader's $148 as too loose given ATR of 9.71. Hard re-engagement requires all four gates plus tier-1 sell-side broadening; pair-trade alternative is long RTX or GE Aerospace vs. short HONA to capture structural-quality spread.

Outcome

✓

Return

-2.62%

Status

scored

Exit the remaining HONA position at market over 1-2 sessions with limit orders. The structural floor at $156-164 has been validated across 17+ sessions despite bear catalysts (700 bps margin compression, $581M payables stretching, guidance cut), and maintaining residual exposure functions as a hidden long bet that the 8/27 reflection explicitly prohibits. The $145 price target represents full exit with no re-entry until Q3 2026 earnings prints and either operating margin recovery (structural floor breaking) or margin stabilization (bear anchors transient).

Outcome

✗

Return

+1.01%

Status

scored

The analyst maintains an UNDERWEIGHT rating with moderate-high conviction on HONA, trimming 50-60% of existing exposure while cutting residual to under 50bps. Key bearish anchors include gross margin compression (37.45% to 34.96%), a guidance cut, receivables outpacing revenue by 1.6pp, $15.85B debt with FCF covering less than 25% of interest, and 17.6x forward P/E with no margin of safety. However, the structural floor ($1.06B cash, $448M quarterly FCF, IndiGo 810-aircraft backlog) prevents escalation to a full SELL. Re-engagement requires all three gates: price sustained above $172 on expanding volume for 5 sessions, Q3 operating margin at least 18% with SG&A growth under 15%, and inventory declining or receivables growth matching revenue growth.

Outcome

✓

Return

-1.99%

Status

scored

Underweight rating maintained with 50-60% trim recommendation at $164, rejecting both the conservative analyst's 75-100% reduction and the trader's outright SELL escalation. A 35-40% residual position at 75bps-1% of book is sized for asymmetric Q3 2026 margin recovery optionality, with hard stop at $156.00 crash low and three-part re-engagement framework requiring simultaneous price, fundamentals, and tier-1 sell-side confirmation.

Outcome

✗

Return

+2.28%

Status

scored

Underweight rating maintained with a 25-35% trim recommendation to reduce HONA exposure, keeping a ~55-65% core position. A hard stop at $148 on closing basis is confirmed across all prior decision dates (8/12, 8/14, 8/18, 8/20, 8/21, 8/24), with mechanical re-entry requiring price above $166.47 on >3M volume with MACD bullish crossover, Q3 2026 earnings showing operating margin ≥15% and gross margin ≥34.5%, and tier-1 sell-side broadening beyond Morgan Stanley. Any re-entry uses half-normal sizing until ATR compresses below 4% of price.

Outcome

✓

Return

-0.52%

Status

scored

Underweight HONA via 30-50% trim of existing exposure over the next 1-2 weeks, keeping a small residual core position due to structurally real valuation support ($448M quarterly FCF, $1.06B cash, tier-one aerospace franchise), while avoiding new longs and outright shorts given MS sponsorship and squeeze risk. Hard stop at $148 on a closing basis, with Q3 earnings in late October/early November as the next fundamental re-evaluation point.

Outcome

✓

Return

-2.14%

Status

scored

Trim HONA to Underweight by reducing 30-50% of existing exposure at $165.89 toward an approximately 50% benchmark weight target, maintaining ~50% core for asymmetric Q3 2026 participation. Reject the trader's $172 SELL stop as mechanically unsound—above-entry stops on directional sell signals guarantee noise-driven cover; use hard stop at $148 on residual instead. Avoid initiating new longs until price reclaims $170.37 on >3M volume, with Q3 2026 earnings (late October) serving as the binary re-engagement checkpoint.

Outcome

✓

Return

-0.70%

Status

scored

Trim 20-25% of HONA from $165.89 while maintaining 75-80% core for the structural thesis, calibrated between an aggressive 33-50% trim and passive Hold per recent lessons; hard stop at $155 on volume >6M shares with Q3 2026 earnings (late October/early November) serving as the binary checkpoint to validate margin stabilization or confirm the bear deterioration thesis.

Outcome

✓

Return

-2.63%

Status

scored

Maintain HONA at current average weight with no incremental adds at $170.37; the 23% gap below the 50/200 SMA cluster at 209.70 defines a still-broken regime requiring measured HOLD rather than aggressive positioning. Hard stop at $161.56 on closing basis triggers a 25-30% trim, while adding is only justified on confirmed close >$175 with above-average volume (3M+ shares), with Q3 2026 earnings as the structural checkpoint for potential rating upgrade.

Outcome

–

Return

+5.98%

Status

scored

HONA is rated Underweight with a recommendation to trim 30-50% of existing exposure at $160.76 while maintaining a ~50% core position as a low-probability asymmetric option. A hard stop is set at $148.00 (below lower Bollinger Band and $150 psychological level) rather than the proposed $160.41 which would be noise-driven. Re-entry requires at least two of three confirmations: sustained close above $171.52 with volume >3M shares, Q3 earnings showing margin recovery above 16% with SG&A below $700M, or yield stabilization/defense catalyst confirmation.

Outcome

✓

Return

-0.50%

Status

scored

Maintain HOLD on HONA at $161.56 with existing positions only—the structural bull case (17.5x forward P/E, $448M quarterly FCF, $2.7B deferred revenue, $9.20 consensus EPS path) is real but pulled equally by unfinished technicals (MACD -13.40 expanding, RSI 34.40, lower Bollinger Band at $146.77) and an empty near-term catalyst calendar (Q3 earnings 3 months away); risk-reward is 1.07:1, not the 2.5:1 bull thesis requires. Position sizing capped at 1-2% portfolio with hard stop at $135 for held positions only; add-trigger requires 2 of 3 technical confirmations (10 EMA reclaim at $173.91, MACD contraction, RSI divergence) plus positive supply-chain commentary.

Outcome

✓

Return

-2.89%

Status

scored

Trim 50% of HONA exposure on any relief bounce into the $173-178 resistance zone rather than chasing the close at $166.36, with a hard stop at $148 on the residual position; do not initiate new longs. The bearish thesis is grounded in 4.1x net leverage, negative book equity, gross margin compression (38.3% to 34.8%), and a $9.20 forward EPS consensus requiring 66% sequential improvement, but the $2.7B deferred revenue and ~6% FCF yield provide a floor preventing escalation to full Sell. The Q3 2026 earnings print in late October is the structural re-evaluation checkpoint.

Outcome

–

Return

-2.03%

Status

scored

Maintain Underweight rating at 50% benchmark weight, trimming via tranche execution in the $173-178 resistance zone rather than chasing the exit at $169.81; use ATR-based trailing stop (~$21-28 wide) instead of fixed $156.47 panic-low stop; re-engagement requires Q3 earnings showing OpEx stabilization with gross margin >35%, close above $194.25 Bollinger middle on >5M volume, or successful higher-low retest of $156.47.

Outcome

✓

Return

+1.20%

Status

scored

Maintain HONA at average weight with a hard stop at $148 and a protective put hedge at the $150 strike (60-90 DTE) costing 1-2% of NAV. The HOLD is risk-managed neutrality following a 28% two-day collapse—not a quiet long or quiet short. Pre-commit two post-Q3 paths: add 25% on clean SG&A normalization with stop tightened to $165 and target $200, or exit if $148 breaks on volume after another margin disappointment.

Outcome

✗

Return

+1.13%

Status

scored

Trim 35-45% of HONA exposure at $165.93, hedged with a protective put at the $150 strike (60-90 DTE) to cap residual downside; hard stop on close below $154.00. Do not initiate new longs. Tactical price target $145 over 6-12 weeks; structural re-evaluation at Q3 2026 print (~8 weeks out).

Outcome

✗

Return

+1.74%

Status

scored

Trim 30-40% of the position at current levels (~$163) rather than executing the trader's full 50% or analyst's 60-70% trim—both of which would be selling into an already-completed capitulation (RSI 33.55, lower Bollinger Band violated, intraday low $150.03). Hedge the residual with a protective put at $150 strike (60-90 DTE) to cap downside at defined cost, with a hard stop on any residual if daily close breaks below $150.03. Price target $145 over 6-12 weeks, with full structural re-evaluation at Q3 print (~8 weeks out).

Outcome

✓

Return

-3.22%

Status

scored

Aggressively trim 75-100% of long positions in the $168-170 zone to lock in capital from the prior drawdown, while maintaining some exposure through defined-risk put spreads rather than naked shorts to protect against the binary M&A catalyst. Re-engagement requires either a daily close above the 10 EMA (~$193.40) with RSI > 50 for three consecutive sessions, or an announced accretive M&A deal; price target is $145 over a 6-12 week tactical horizon with full structural re-evaluation at Q2 earnings.